Ionisos, leading European provider of cold sterilisation services, has announced its purchase of Steril Milano, a specialist in sterilisation services.
Established in 2009 and based in Monza, Italy, Steril Milano is the Italian leading specialist in ethylene oxide sterilisation. Through this acquisition, Ionisos will enter the Italian market where MedTech and packaging provide a strong client basis.
Christoph Herkens, CEO of Ionisos, said: “This acquisition is fully in line with our growth strategy and strengthens our European footprint by opening a new country. We will also expand our sterilisation services through the construction of a new facility close to Milano.”
Carlo Salvetti, founder and CEO of Steril Milano, said: “Within only ten years Steril Milano has become the leading partner for ethylene oxide-based sterilisation services in the Italian market. As part of a multinational group we can further accelerate growth and offer even broader services to our clients in ethylene oxide, eBeam and x-ray.”
François Jerphagnon, Head of the Ardian Expansion team, adds: “This is the fifth acquisition performed by Ionisos since our entry in July 2016. We keep on consolidating the market in order to turn Ionisos into a European leader in cold sterilisation.”
Ionisos is a French company founded in 1993, which manages eleven plants in France, Spain, Germany, Estonia and now Italy. Ionisos is a specialist in cold sterilisation using ionisation and ethylene oxide for the medical sector, pharmaceutical products, cosmetics and food packaging. The company is also active in the cross-linking of various products used in industry, particularly the automotive industry.
About Steril Milano
Created in 2009 and based in Monza in Italy, Steril Milano is the Italian leader in cold sterilisation services for third parties, with a strong know-how in ethylene oxide. The installed capacities, in Monza and Reggiolo, allow the company to offer a diversified range of activities from sterilisation of medical devices to consulting services for sterile processes and products. The new site in Biassono will be operational from Jan 2020 onwards with eBeam, X-ray and ethylene oxide services and will be the major site of cold sterilisation in Italy and the only one offering three sterilisation technologies.
The services will brand under Ionisos Italia (irradiation) and Sterylene Italia (ethylene oxide).
Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of $90bn managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fuelling growth in economies across the world. Ardian’s investment process embodies three values: excellence, loyalty and entrepreneurship.
Ardian maintains a truly global network, with more than 600 employees working through fifteen offices in Paris, London, Frankfurt, Milan, Madrid, Zurich, New York, San Francisco, Beijing, Singapore, Jersey, Luxembourg, Seoul, Santiago and Tokyo. The company offers to its 880 investors a diversified choice of funds covering the full range of asset classes, including Ardian Funds of Funds (primary, early secondary and secondary), Ardian Private Debt, Ardian Direct Funds (including Ardian Buyout Europe & North America, Ardian Expansion, Ardian Growth and Ardian Co-Investment), Ardian Infrastructure, Ardian Real Estate and Ardian Mandates.
For more information on the products and services provided by Ionisos, please fill out the enquiry form on this page.